Skip to main content
Netherlands News in English

Main navigation

  • Top stories
  • Health
  • Crime
  • Politics
  • Business
  • Tech
  • Culture
  • Sports
  • Weird
  • 1-1-2
Image
Philips
Philips - Credit: alexeynovikov / DepositPhotos - License: DepositPhotos
Business
Philips
VEB
Amsterdam
court of appeal
recall
sleep apnea
sleep apnea device
Sunday, 28 June 2026 - 07:45

Share this article:

Opens in a new window Opens in a new window Opens in a new window Opens in a new window Opens in a new window Opens in a new window

Investors demand new deep probe into Philips over sleep apnea device scandal

Investor lawyers are again calling for a deep investigation into Royal Philips, warning that a repeat of the company’s apnea-device crisis cannot be ruled out. They allege the Dutch medical technology company failed to disclose problems in time involving deteriorating foam in breathing devices that triggered a 2021 recall of millions of units.

The renewed pressure comes from shareholder representatives who argue Philips mismanaged warning signs for years. They say issues at the company’s U.S. ventilation subsidiary were already known by 2015, when the U.S. Food and Drug Administration warned that its complaint-handling system was not properly functioning. Investors argue the company should have acted much earlier at the leadership level.

The 2021 recall led to widespread device withdrawals, significant financial losses and a sharp decline in Philips’ share price.

Investor groups, including the Dutch Shareholders’ Association (VEB), now seek to hold Philips liable for damages. They say a formal, in-depth inquiry is necessary to assess responsibility and recover losses. Asset manager Vanguard, along with pension funds and insurers, has also joined the request for an investigation.

The VEB has asked the Dutch Enterprise Chamber to appoint an independent official at Philips to oversee potential settlement talks and address alleged conflicts of interest involving CEO Roy Jakobs, who previously led the division responsible for the apnea devices.

Philips rejects the allegations, saying shareholders are interpreting disclosures with hindsight. The company maintains there were no clear signals of elevated health risks before the recall and that complaint levels remained limited. It also argues that the recall does not prove a systemic failure in its internal systems.

Former CEO Frans van Houten said the recall had a major impact on patients, shareholders and other stakeholders. He added that Philips consistently communicated about the situation and acted responsibly throughout the process.

Reporting by ANP and NL Times

More like this

Image
Philips
Dutch investors request court investigation into Philips sleep apnea scandal
Image
Philips Dreamstation sleep apnea machine
Philips allegedly hid 3,700 complaints about sleep apnea machines from U.S. authority
Image
Philips
Philips books €897 million profit in 2025; First annual profit since 2021
Image
Philips
Philips suffered €698 million loss last year, mainly over $1.1 billion recall settlement
Make NL Times your top Google source

Follow us:

Latest stories

  • Dutch municipalities block local fireworks shows as national ban begins
  • Netherlands and France set to formally establish a border on Sint Maarten
  • WhatsApp blocks Dutch sex workers, cutting off their income
  • Family appealing no-prosecution ruling for police officer who fatally shot 15-year-old
  • Dutch variable gas prices rise 12% above pre-Middle East war levels

Top stories

  • Man shot inside Amsterdam-Zuidoost home
  • Second stuntman hurt after being catapulted at Zwarte Cross festival
  • Video: Two suspects arrested after drug lab found in The Hague neighborhood
  • Vitesse can keep its professional football license; Supreme Court rules against KNVB
  • Dutch municipalities still leaking citizen data 9 years after order to tighten security

© 2012-2026, NL Times, All rights reserved.

Footer menu

  • Change Privacy Settings
  • Privacy Policy
  • Contact
  • Partner Content